Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 CEDRA Corp. | Contract Pharma

What are you searching for?

Sign in
Breaking News, Promotions & Moves

CEDRA Corp.

Anthony G. Busa, Jr., has been named chief executive officer of CEDRA Corp., a division of Worldwide Clinical Trials (WCT) and a provider of Phase I clinical research and bioanalytical services.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Anthony G. Busa, Jr., has been named chief executive officer of CEDRA Corp., a division of Worldwide Clinical Trials (WCT) and a provider of Phase I clinical research and bioanalytical services.

Mr. Busa has more than 34 years of experience in management positions including senior level management, regional and national sales and product development within the pharmaceutical and medical device industries. Previously, he held senior management related positions at McClintic Busa Group, LLP, dgd Research, Inc., Esoterix, Inc., Medsites, Inc., and Covance, Inc.

“Anthony is an experienced, high caliber professional. He has a thorough understanding of how this business and industry functions,” said Worldwide Clinical Trials chief operating officer, Tom Wardle. “He will be a great asset to our team in terms of growth and management.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics